CLINICAL TRIALS PROFILE FOR ENTRESTO
✉ Email this page to a colleague
All Clinical Trials for ENTRESTO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02636283 ↗ | Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease | Terminated | American Heart Association | Phase 2 | 2017-12-31 | This study proposes the use of Entresto (sacubitril/valsartan) to test the effects on pain free walking duration on patients with peripheral arterial disease, a condition caused by decreased blood flow to the muscles in the legs. |
NCT02636283 ↗ | Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease | Terminated | University of Minnesota | Phase 2 | 2017-12-31 | This study proposes the use of Entresto (sacubitril/valsartan) to test the effects on pain free walking duration on patients with peripheral arterial disease, a condition caused by decreased blood flow to the muscles in the legs. |
NCT02636283 ↗ | Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease | Terminated | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | 2017-12-31 | This study proposes the use of Entresto (sacubitril/valsartan) to test the effects on pain free walking duration on patients with peripheral arterial disease, a condition caused by decreased blood flow to the muscles in the legs. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ENTRESTO
Condition Name
Clinical Trial Locations for ENTRESTO
Trials by Country
Clinical Trial Progress for ENTRESTO
Clinical Trial Phase
Clinical Trial Sponsors for ENTRESTO
Sponsor Name